GR3005579T3 - - Google Patents

Info

Publication number
GR3005579T3
GR3005579T3 GR920401915T GR920401915T GR3005579T3 GR 3005579 T3 GR3005579 T3 GR 3005579T3 GR 920401915 T GR920401915 T GR 920401915T GR 920401915 T GR920401915 T GR 920401915T GR 3005579 T3 GR3005579 T3 GR 3005579T3
Authority
GR
Greece
Application number
GR920401915T
Other languages
Greek (el)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GR3005579T3 publication Critical patent/GR3005579T3/el

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/32Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827Proteins from mammals or birds
    • Y10S530/84Bones; tendons; teeth; cartilage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Steroid Compounds (AREA)
GR920401915T 1986-08-05 1992-09-01 GR3005579T3 (US08158827-20120417-C00028.png)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3626414A DE3626414C2 (de) 1986-08-05 1986-08-05 Präparat zur Stimulierung von Chondrocyten und Osteoblasten (Ossein-Hydroxyapatit-Komplex), Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel

Publications (1)

Publication Number Publication Date
GR3005579T3 true GR3005579T3 (US08158827-20120417-C00028.png) 1993-06-07

Family

ID=6306689

Family Applications (1)

Application Number Title Priority Date Filing Date
GR920401915T GR3005579T3 (US08158827-20120417-C00028.png) 1986-08-05 1992-09-01

Country Status (20)

Country Link
US (1) US4919931A (US08158827-20120417-C00028.png)
EP (1) EP0255565B1 (US08158827-20120417-C00028.png)
JP (1) JPS6344527A (US08158827-20120417-C00028.png)
KR (2) KR880002897A (US08158827-20120417-C00028.png)
CN (1) CN1028237C (US08158827-20120417-C00028.png)
AR (1) AR242589A1 (US08158827-20120417-C00028.png)
AT (1) ATE77239T1 (US08158827-20120417-C00028.png)
AU (1) AU604014B2 (US08158827-20120417-C00028.png)
CA (1) CA1289878C (US08158827-20120417-C00028.png)
DE (2) DE3626414C2 (US08158827-20120417-C00028.png)
DK (1) DK175488B1 (US08158827-20120417-C00028.png)
ES (1) ES2041647T3 (US08158827-20120417-C00028.png)
FI (1) FI91877C (US08158827-20120417-C00028.png)
GR (1) GR3005579T3 (US08158827-20120417-C00028.png)
HU (1) HU205373B (US08158827-20120417-C00028.png)
IE (1) IE59916B1 (US08158827-20120417-C00028.png)
IL (1) IL82213A (US08158827-20120417-C00028.png)
NO (1) NO173786C (US08158827-20120417-C00028.png)
PT (1) PT84693B (US08158827-20120417-C00028.png)
ZA (1) ZA872701B (US08158827-20120417-C00028.png)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4861590A (en) * 1986-09-25 1989-08-29 Colgate-Palmolive Company Sustained release fluoride and calcium composition
US4859467A (en) * 1986-09-25 1989-08-22 Colgate-Palmotive Company Sustained release fluoride composition
JPH02149618A (ja) * 1988-11-30 1990-06-08 Kobe Steel Ltd 加工性に優れた高強度熱延鋼板の製造方法
CN1045719C (zh) * 1993-04-10 1999-10-20 北京市西城区华新生化技术研究所 口服接骨和治骨质疏松液
EP0635518B1 (en) * 1993-07-23 2003-10-08 Kato, Yukio, Prof. New chondrocyte protein
EP0777491B1 (de) * 1994-08-23 2004-11-17 Deutsche Gelatine-Fabriken Stoess AG Verwendung von geschmacksneutralem, hydrolysiertem kollagen und mittel enthaltend dasselbe
US5788941A (en) * 1996-01-31 1998-08-04 Steris Corporation Method of sterilization of bone tussue
JPH09238291A (ja) * 1996-02-29 1997-09-09 Sony Corp メニュー操作方法及び電子機器及びテレビジョン受像機
NL1020729C2 (nl) * 2002-05-31 2003-12-02 Gelatine Smits Beheer B V Calciumbevattende samenstelling, werkwijze voor het bereiden daarvan, en farmaceutisch preparaat op basis van de samenstelling.
CN1212126C (zh) * 2002-07-09 2005-07-27 中国科学院长春应用化学研究所 纳米羟基磷灰石补钙剂
JP4369969B2 (ja) * 2007-10-26 2009-11-25 株式会社アールビーエス 生体適合性材料並びにその製造方法
DK2699249T3 (en) 2011-04-19 2017-01-09 Bioiberica cartilage Product
RU2478394C1 (ru) * 2011-11-23 2013-04-10 Федеральное государственное бюджетное учреждение "Российский научный центр "Восстановительная травматология и ортопедия" имени академика Г.А. Илизарова" Министерства здравоохранения и социального развития Российской Федерации Биоматериал для возмещения дефектов костей и способ его получения
EP3041482B1 (en) * 2013-09-05 2021-06-09 Waitaki Biosciences High osteocalcin microcrystalline hydroxyapatite for calcium supplement

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE894895C (de) * 1950-03-06 1953-10-29 Albert Dr Reissner Verfahren zur Herstellung eines Praeparates zur Anregung der Zahnerhaltung
BE650626A (US08158827-20120417-C00028.png) * 1962-02-28 1900-01-01
USRE28093E (en) * 1962-02-28 1974-07-30 Wound-healing cartilage powder
US3400199A (en) * 1965-02-26 1968-09-03 Leslie L. Balassa Wound-healing cartilage powder
DE2425266A1 (de) * 1974-05-24 1975-11-27 Lothar Tischmann Zum einnehmen bestimmtes naehr- und heilmittel aus tierischer knochen-substanz und verfahren zu seiner herstellung
DE2840064C2 (de) * 1978-09-14 1989-09-21 Hans Dr.med. Dr.med.dent. 8000 München Scheicher Verfahren zur Herstellung von Knochenkontaktschichten
US4232425A (en) * 1980-01-15 1980-11-11 Darling & Company Method of producing stabilized bone
US4455256A (en) * 1981-05-05 1984-06-19 The Regents Of The University Of California Bone morphogenetic protein
US4294753A (en) * 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
ZA816771B (en) * 1980-10-07 1982-10-27 Lensfield Prod Ltd Protein production
US4444752A (en) * 1982-09-13 1984-04-24 Lescarden Ltd. Method for treating progressive systemic sclerosis
US4436720A (en) * 1983-03-04 1984-03-13 Pakhomov Gennady N Granulated treatment-and-prophylactic dental preparation possessing anticarious effect
NZ210699A (en) * 1984-01-04 1989-06-28 Int Genetic Eng Isolation of an osteogenic protein of the p3 immunologically related family
DE3409372A1 (de) * 1984-03-14 1985-09-19 Dr. Ruhland Nachf. GmbH, 8425 Neustadt Material zum vitalisieren von implantatoberflaechen
DE3422466C1 (de) * 1984-06-16 1986-03-20 Lothar 6750 Kaiserslautern Tischmann Verfahren zum Herstellen eines eßbaren, proteinhaltigen Knochenmehlpräparates aus frischen Tierknochen
US4620327A (en) * 1984-07-05 1986-11-04 Caplan Arnold I Process of adapting soluble bone protein for use in stimulating osteoinduction

Also Published As

Publication number Publication date
AR242589A1 (es) 1993-04-30
AU604014B2 (en) 1990-12-06
AU7157787A (en) 1988-02-11
ATE77239T1 (de) 1992-07-15
DE3626414C2 (de) 1994-11-10
FI91877C (fi) 1994-08-25
CA1289878C (en) 1991-10-01
NO871599L (no) 1988-02-08
HUT44047A (en) 1988-01-28
JPS6344527A (ja) 1988-02-25
IL82213A0 (en) 1987-10-30
EP0255565B1 (en) 1992-06-17
FI871670A0 (fi) 1987-04-15
PT84693B (pt) 1990-06-29
PT84693A (en) 1987-05-01
NO173786B (no) 1993-10-25
DK175488B1 (da) 2004-11-08
DK196387D0 (da) 1987-04-15
KR880002897A (ko) 1988-05-12
IL82213A (en) 1991-08-16
FI871670A (fi) 1988-02-06
NO173786C (no) 1994-02-02
US4919931A (en) 1990-04-24
CN1028237C (zh) 1995-04-19
HU205373B (en) 1992-04-28
DE3626414A1 (de) 1988-02-11
EP0255565A3 (en) 1990-01-31
IE870983L (en) 1988-02-05
JPH0558606B2 (US08158827-20120417-C00028.png) 1993-08-27
DE3779829T2 (de) 1993-01-14
ZA872701B (en) 1987-11-25
EP0255565A2 (en) 1988-02-10
NO871599D0 (no) 1987-04-15
ES2041647T3 (es) 1993-12-01
FI91877B (fi) 1994-05-13
DK196387A (da) 1988-02-06
KR880002534A (ko) 1988-05-09
DE3779829D1 (de) 1992-07-23
IE59916B1 (en) 1994-04-20
KR960009651B1 (en) 1996-07-23
CN87102744A (zh) 1988-02-17

Similar Documents

Publication Publication Date Title
AU7131891A (US08158827-20120417-C00028.png)
DE3790178T1 (US08158827-20120417-C00028.png)
AU7354491A (US08158827-20120417-C00028.png)
DE3790600T1 (US08158827-20120417-C00028.png)
CH669517B (US08158827-20120417-C00028.png)
AU7131791A (US08158827-20120417-C00028.png)
AU5655786A (US08158827-20120417-C00028.png)
AU5724586A (US08158827-20120417-C00028.png)
AU4946385A (US08158827-20120417-C00028.png)
AU4375585A (US08158827-20120417-C00028.png)
AU5130385A (US08158827-20120417-C00028.png)
AU5173485A (US08158827-20120417-C00028.png)
AU5227086A (US08158827-20120417-C00028.png)
AU5257190A (US08158827-20120417-C00028.png)
AU5329886A (US08158827-20120417-C00028.png)
AU5344086A (US08158827-20120417-C00028.png)
AU5442686A (US08158827-20120417-C00028.png)
AU5444986A (US08158827-20120417-C00028.png)
AU5537386A (US08158827-20120417-C00028.png)
AU5558386A (US08158827-20120417-C00028.png)
AU5597686A (US08158827-20120417-C00028.png)
AU5614386A (US08158827-20120417-C00028.png)
AU5614486A (US08158827-20120417-C00028.png)
AU5644686A (US08158827-20120417-C00028.png)
AU5348186A (US08158827-20120417-C00028.png)